期刊
EMBO JOURNAL
卷 31, 期 3, 页码 679-691出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/emboj.2011.417
关键词
activation-induced deaminase; antibody diversification; DnaJa1; farnesylation; Hsp40
资金
- Canadian Institutes of Health Research [MOP-84543]
- Canadian Fund for Innovation LOF
- Cole Foundation
- Canada Research Chair Tier 2
The enzyme activation-induced deaminase (AID) deaminates deoxycytidine at the immunoglobulin genes, thereby initiating antibody affinity maturation and isotype class switching during immune responses. In contrast, off-target DNA damage caused by AID is oncogenic. Central to balancing immunity and cancer is AID regulation, including the mechanisms determining AID protein levels. We describe a specific functional interaction between AID and the Hsp40 DnaJa1, which provides insight into the function of both proteins. Although both major cytoplasmic type I Hsp40s, DnaJa1 and DnaJa2, are induced upon B-cell activation and interact with AID in vitro, only DnaJa1 overexpression increases AID levels and biological activity in cell lines. Conversely, DnaJa1, but not DnaJa2, depletion reduces AID levels, stability and isotype switching. In vivo, DnaJa1-deficient mice display compromised response to immunization, AID protein and isotype switching levels being reduced by half. Moreover, DnaJa1 farnesylation is required to maintain, and farnesyltransferase inhibition reduces, AID protein levels in B cells. Thus, DnaJa1 is a limiting factor that plays a non-redundant role in the functional stabilization of AID. The EMBO Journal (2012) 31, 679-691. doi:10.1038/emboj.2011.417; Published online 15 November 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据